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The proven existence of an
apparently healthy human clone,
however, would deflate the
criticism of cloning scientists
including Ian Wilmut and Rudolf
Jaenisch, who extrapolate from
the animal experiments that the
risk for the cloned baby would be
unacceptably high. On the
contrary, if failed attempts at
reproductive cloning became
public, there could possibly be an
enormous political backlash which
might also affect animal cloning,
therapeutic cloning and stem cell
research. Therefore, researchers
active in these fields have reacted
angrily against any claims that
human reproductive cloning might
already be possible.
Apart from the risk arising from
the lack of scientific
understanding of the processes
involved, there are ethical
concerns mainly hinging on two
key points: interfering with human
reproduction in an unnatural way,
and production of ‘identical
copies’ of human beings.
Discussions of the first point
sound like an echo of the debate
about in vitro fertilisation (IVF) 25
years ago. Patients claim the right
to children with their own genes,
while some religious
fundamentalists want the
reproduction process to remain
taboo. The experience with IVF
suggests that, as time and
technology move on, new
methods become widely accepted
as long as they are safe and
useful. Today, thousands of IVF
babies are born every year, and
nobody makes a fuss about it.
The ‘identity’ aspect of
reproductive cloning is often
misrepresented in the media. The
fact is that nobody will ever be
able to create an identical copy of
an existing human being, as
nobody will be able to recreate
the conditions that the clonee in
question experienced in the
womb. It is well-known that
hormone exposure during the
gestation period can influence a
range of characteristic properties,
including even sexual orientation.
Thus, any clone baby will
resemble their one and only
parent more closely than ordinary
children, but not as closely as
identical twins. 
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Even if many countries ban it for
religious or ethical reasons or for
fear of the safety of the
procedure, there will be others
that don’t, so it seems likely that
efforts will continue, particularly
given the determined, difficult or
sometimes distressing personal
circumstances surrounding
people seeking to create a clone.
There is, however, a chance that
the association between cloning
and fertility treatment might at
some stage be dissociated.
According to recent press
reports, researchers at a fertility
clinic in Sao Paolo, Brazil,
succeeded in reducing the double
(diploid) chromosome set of a
human body cell to a single
(haploid) set, introducing this into
a denucleated egg cell, and
fertilizing the construct with a
normal sperm. The researchers
then claimed that the fertilized egg
started to develop normally.
Reportedly they froze the resulting
embryo indefinitely to allow time
for further experiments with this
haploidization technique in
animals to confirm whether or not
their results are plausible, given
the very surprising claims. 
Could it be possible, even in
principle at this stage, that
haploidized body cell DNA could
be introduced into both the egg
and the sperm. This would imply
that offspring with a recombined
genetic heritage could be
produced from any combination of
parents, be they infertile, a
homosexual couple or even
deceased. Such a reproduction
technique would of course create
a new round of the IVF-style
debate on what is ‘natural’ and
what is not, but it would
dissociate cloning from fertility
treatment. And considering the
current debate enriched by
visiting aliens and unproven
claims, this prospect might not be
such a bad thing.
Michael Gross is a science writer in
residence at the school of
crystallography, Birkbeck College,
University of London. He can be
contacted through his web page at
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Mediawatch: The news agenda can be tough for science journalists
trying to attract interest in their stories but, as Richard Harris reports,
getting the word ‘cloning’ into a piece can see surprising stories hitting
the front page and a battle of definitions for researchers trying to
explain their work. 
Once upon a time, cancer was
such an unspeakable disease that
Americans couldn’t even utter its
name. It was sometimes called
simply, ‘The Big C’. These days,
cancer is no longer such a taboo.
Chemotherapy patients even pull
off their wigs to affirm their lack of
embarrassment. But there’s a
new, unspeakable ‘Big C’ that has
taken hold. Cloning.
This is the story of a program at
Stanford University that is seeking
new inroads to cancer. A carefully
worded press release deftly
avoided the word ‘cloning’ when
discussing the techniques of cell
biology that will be brought to
bear to alleviate human misery at
the new institute. But the
Associated Press was not fooled.
In a wire service dispatch
released in response, the AP sent
out an urgent story on the
highest-priority wire: ‘Stanford
University launches human
embryo cloning project, first US
school to publicly embrace such a
procedure.’ The AP put this story
on a list of stories deserving play
on Page One.
Alarm bells sounded in
newsrooms across America, and
reporters started calling Stanford
to get the story. At first, Stanford
simply blamed the AP for
overzealous and inaccurate
reporting. Stanford even issued
an additional press release
stating that, ‘Stanford University
is not cloning human embryos. A
story published today by the
Associated Press incorrectly
characterized the nature of
research that would take place at
the newly announced Institute for
Cancer/Stem Cell Biology and
Medicine at the Stanford
University School of Medicine.’
At stake in this rhetorical battle
was the definition of ‘cloning’. It’s
a term abhorred by religious
fundamentalists, feared by
scientists and deployed as
forcefully as TNT by journalists.
Stanford won Round One in this
battle. The AP retreated a bit with
a new headline: ‘Stanford
University announces
controversial human embryonic
stem cell project.’ The lead was
softened to state that ‘Stanford
University reignited the debate
over the use of stem cells when a
top scientist said the school
intended to experiment with
nuclear transfer technology, an
effort many consider to be
cloning.’
The AP noted that, though
Stanford objected to the term
‘cloning’ in its portrayal of
somatic cell nuclear transfer, it’s
a ‘distinction without a
difference.’
‘The American Association of
Medical Colleges, of which
Stanford is a member, defines it
this way: ‘Somatic Cell Nuclear
Transfer (SCNT) or therapeutic
cloning involves removing the
nucleus of an unfertilized egg cell,
replacing it with the material from
the nucleus of a `somatic cell’ (a
skin, heart, or nerve cell, for
example), and stimulating this cell
to begin dividing’.’
Stanford’s effort at spin-control
included an evening news
conference. That helped shape
the tone of the story, largely away
from controversy and more
toward touting the benefits of
such research. The San Jose
Mercury News, for example,
started its story like this:
‘Convinced that stem cells will
provide key insight into diseases
such as cancer, Parkinson’s and
diabetes, Stanford University
announced Tuesday it was
launching a new institute to
cultivate and study stem cells —
and might someday attempt a
legal but controversial form of
cloning human embryos.’
Likewise, the San Francisco
Chronicle topped its piece with
this benign headline: ‘Stanford
plans stem-cell institute/Center
will also focus on related cancer
research.’
The paper reported that, ‘Much
of the work involves a technology
scientists call nuclear transfer, in
which genetic material from an
adult cell is transferred into the
hollowed-out nucleus of a stem
cell, which is then allowed to
replicate. Some of the initial steps
are identical to those used in
reproductive cloning. But the
stem-cell work is not designed to
produce any new offspring.’
The Los Angeles Times,
though, rejected the spin that
Stanford attempted to put on the
story. It reported ‘Stanford
University on Tuesday announced
plans to create new types of
embryonic stem cells that might
require its researchers to
eventually attempt a form of
human cloning.’
It was ultimately the Wall Street
Journal that parsed the word
‘cloning’ carefully enough to cut
through the rhetorical fight for
high ground. The Journal quoted
Irving Weissman, who will head
the new Stanford Institute,
explaining exactly how he
justified dancing around the
supercharged term of ‘cloning.’
‘‘We call it nuclear
transplantation to produce
embryonic stem-cell lines. We
don’t call it cloning,’ he told the
Journal. ‘The big difference isn’t
how you start but what you do
with the cells. In therapeutic
cloning, you want cells that are
transplantable. In nuclear
transfer, you’re producing cell
lines for research.’
The Journal went on with
Weissman’s explanation: ‘True
clones are organisms that arise
from a single cell, but ... his
recipe for stem-cell lines involves
using ‘tens of cells’ arising from
eggs with nuclear transplants.’
Of course, people have long
battled over words to help frame
debates, whether the topic is
‘pro-life’ (anti-abortion) or ‘trickle-
down’ economics (policies that
benefit the rich). In this case,
Janet Rossant from Mt. Sinai
Hospital in Toronto told a
colleague of mine at National
Public Radio, ‘I think the
distinction between cloning for
reproduction and cloning for
making embryonic stem cells is
one that is difficult to explain to
the public, and I don’t think we
can get around that difficulty by
trying to say it’s not cloning.’
Richard F. Harris is a science
correspondent at National Public Radio
and past president of the National
Association of Science Writers. Email:
rharris@nasw.org
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Needling: Scientists and journalists have sometimes got into a battle of words involv-
ing micromanipulation techniques involving eggs and embryo cells. (Picture: Science
Photo Library, London.) 
